Published in Nature Communications · View the paper (DOI)
Researchers developed a vaccine that targets flagellin in the gut microbiota to reduce inflammation. The vaccine showed protection against intestinal inflammation and metabolic disorders such as diabetes and obesity.
Coverage from 2 institutions
- A vaccine against chronic inflammatory diseases INSERM (Institut national de la santé et de la recherche médicale) · Dec 11, 2019 · first to report
- Researchers develop approach to alter intestinal microbiota, vaccinate against inflammatory diseases Georgia State University · Dec 11, 2019